# AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

> **NCT00121758** · PHASE2 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 156 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** LIPO-5

## Key facts

- **NCT ID:** NCT00121758
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2008-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121758, "AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00121758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*